Authorisation import/export

An authorisation is required to import and export drug precursors within and outside the European Union:

• Category 1: authorisation required for both import and export.
• Category 2 and 4: only an export authorisation required.
• Category 3: export to countries known to be highly drug-sensitive requires an export authorisation.

Such an authorisation can only be used once and for one shipment, and may contain a maximum of two scheduled substances.

Application procedure
The application should be made using the application forms below:

- Request for export authorisation

- Request for import authorisation

Applications must be signed by the responsible person or his deputy.

The completed and signed application forms, together with any supporting documents, must be sent by e-mail to drugprecursor@afmps-fagg.be

Only signed and correctly completed applications will be considered. The application must bear a manual signature that can subsequently be scanned, or a digital signature that meets the requirements of an electronically qualified signature.

Additional information
The information below on the application form can also be reported later to the customs office of exit or other competent authority at the point of exit where the substances leave the European Union.
Before departure, the following boxes on the authorisations should be completed:

• Import authorisation: boxes 7, 9 and 10.
• Export authorisation: boxes 7, 8, 10, 11, 12 and 13.

Retention of original documents
The original application and original supporting documents should be kept and held available for the officials of the Customs and Excise Administration, the FAMHP and the officers of the Federal Police.

Validity

• Import authorisation: valid for six months after issuance.
• Export authorisation: valid for up to six months after issuance.

Scheduled substances must have entered or left the European Union customs territory within the validity period. 
The competent authorities may suspend or revoke the import or export authorisation if there is suspicion that the substances are intended for the illegal manufacture of drugs.

Return of authorisation copies

• Import authorisation: copy No. 3 accompanies the scheduled substance from the point of entry into the customs territory of the Union to the business premises of the importer, who shall send this copy to the FAMHP by post.
• Export authorisation: copy No. 2 accompanies the scheduled substance and must be presented to the customs office where the customs export declaration is made, and subsequently to the competent authority at the point of exit from the customs territory of the Union. The competent authority at the point of exit shall return copy No. 2 to the FAMHP by post.

Cancellation
Authorisations that are not used should be returned to the FAMHP Precursors team by post in all copies no later than the expiry date.

Fees
For import or export authorisations issued, a fee is due to the FAMHP.

These fees are indexed each year.
Please note that these fees no longer need to be paid up-front but will be invoiced once the authorisation has been issued.